Indian Army Department Of Military Affairs Medicines Tender 2026 Injection Eye Drops - 25% Quantity Option, 50,000 Estimated Value

Tender Overview

The Indian Army, Department Of Military Affairs, seeks a supply-only tender for a diverse range of pharmaceutical products including injections (Amoxycillin with Clavulanic acid, Pheniramine Maleate, Pantoprazole, Sodium Bicarbonate, Calcium combinations, Etophylline/Theophylline, Tonophosphan, B Complex Neurobion Forte), eye drops (Moxifloxacin/Dexamethasone), Clarithromycin tablets, and disposable syringes. Estimated value is ₹50,000 with a total of 11 items referenced in the BOQ, though item-specific quantities are not disclosed. The contract permits a 25% quantity variation during award and currency, with delivery timelines tied to the original/extended periods. This is a supply-only procurement, emphasizing compliance with delivery and price constancy at contracted rates. A unique option clause governs post-award quantity adjustments and delivery scheduling.

Key differentiator: explicit option clause enabling quantity and delivery adjustments up to 25% and a calculated delivery extension based on (Increased quantity ÷ Original quantity) × Original delivery period, with a minimum of 30 days. This tender targets reliable pharmaceutical suppliers capable of bulk, compliant medical-goods delivery to a defense buyer.

Technical Specifications & Requirements

• Product categories include: injectables, eye drops, tablets, and syringes across 11 items; no specific technical specs disclosed in the tender data. The scope requires goods-only supply with all costs included in the bid price. The terms emphasize order-quantity flexibility and adherence to contracted rates during currency.
• Although itemized details are not published, bidders should ensure readiness for rapid provisioning of multiple SKUs within the listed categories, with a focus on on-time delivery and price stability. Vendors should be prepared to align with defense procurement norms and maintain traceability of pharmaceutical inputs. The absence of explicit standards means bidders must rely on general GMP-compliant supply capabilities and robust quality control.
• EMD and precise item-level specifications are not specified in the public data; bidders should confirm documentary readiness and confirm scope of supply with the buyer during clarification windows.

Terms, Conditions & Eligibility

• Option Clause: Purchaser may increase/decrease quantity up to 25% of bid/contract quantity; extended delivery period calculated as (Increased quantity ÷ Original quantity) × Original delivery period, minimum 30 days.
• Scope of Supply: Bid price must include all costs; only supply of Goods.
• Delivery and payment terms align with standard government procurement practices; bidders should ensure readiness for delivery within the extended window and adherence to contracted rates during currency.